Guardian Wealth Management Inc. grew its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,182 shares of the company’s stock after buying an additional 250 shares during the quarter. Procter & Gamble accounts for 1.9% of Guardian Wealth Management Inc.’s investment portfolio, making the stock its 19th largest holding. Guardian Wealth Management Inc.’s holdings in Procter & Gamble were worth $2,630,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. FMR LLC grew its position in Procter & Gamble by 2.7% during the third quarter. FMR LLC now owns 26,556,319 shares of the company’s stock worth $4,599,554,000 after buying an additional 689,282 shares during the period. Legal & General Group Plc grew its holdings in shares of Procter & Gamble by 0.6% in the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock worth $3,567,556,000 after acquiring an additional 122,190 shares during the period. Fisher Asset Management LLC increased its stake in Procter & Gamble by 4.7% in the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock valued at $3,183,522,000 after purchasing an additional 830,476 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in Procter & Gamble by 0.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 16,422,470 shares of the company’s stock worth $2,844,442,000 after purchasing an additional 105,734 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Procter & Gamble by 3.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,049,651 shares of the company’s stock worth $2,433,400,000 after purchasing an additional 426,409 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the stock. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. JPMorgan Chase & Co. increased their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a research report on Thursday, August 29th. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Finally, Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $180.45.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares of the company’s stock, valued at $2,002,804.35. The trade was a 52.47 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 83,080 shares of company stock valued at $14,629,038. Corporate insiders own 0.18% of the company’s stock.
Procter & Gamble Stock Performance
Shares of PG opened at $173.82 on Monday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $180.43. The firm has a fifty day moving average of $170.76 and a 200-day moving average of $169.40. The company has a market cap of $409.35 billion, a price-to-earnings ratio of 29.97, a price-to-earnings-growth ratio of 3.75 and a beta of 0.44.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the firm posted $1.83 earnings per share. The business’s revenue was down .6% on a year-over-year basis. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.32%. Procter & Gamble’s dividend payout ratio is presently 69.48%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Trading Halts Explained
- Consumer Discretionary Stocks Soar but Is a Pullback Looming?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- RoaringKitty Returns: Can Meme Stocks Stage a Comeback?
- 3 REITs to Buy and Hold for the Long Term
- Sleighing the Market: 3 Holiday Stock Winners
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.